Corcept Therapeutics (NASDAQ:CORT): Q1 Non-GAAP EPS of $0.34 beats by $0.13; GAAP EPS of $0.25 beats by $0.03.
Revenue of $93.2M (+43.8% Y/Y) beats by $6.19M.
https://seekingalpha.com/news/3568623-corcept-therapeutics-eps-beats-0_13-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.